Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The history adds that the study is no longer recruiting participants, and notes Revision: v3.6.0, replacing the prior v3.5.5 in the revision history.
    Difference
    0.2%
    Check dated 2026-06-12T14:27:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing Revision: v3.5.4. This metadata update indicates the site's revision version is current and does not alter the study history content.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page's revision label updates from Revision: v3.5.3 to Revision: v3.5.4. This indicates a newer version of the page rendering.
    Difference
    0.0%
    Check dated 2026-05-15T06:13:05.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page’s displayed software/UI revision number from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:33.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0 from the history.
    Difference
    0.0%
    Check dated 2026-04-17T02:46:02.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-02T15:34:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.